More than three million people across the globe have died of Covid-19 in the roughly nine months since India and South Africa first proposed a temporary patent waiver for coronavirus vaccines, a popular measure that Germany, the United Kingdom, Canada, and other rich countries have blocked.
Most of that money, said a spokesperson for the group, “will go directly into the pockets” of Big Pharma shareholders.
India’s Ministry of External Affairs has welcomed the statement of the US government of 5th May announcing their support for a relaxation in the norms of the agreement on TRIPS, to ensure quick and affordable access to vaccines and medicines for developing countries. Delhi is “hopeful that with a consensus based approach, the waiver can be approved quickly at the WTO.” But is the optimism warranted? More
So countries meet again tomorrow for another round of discussion on #TRIPSwaiver @WTO. Even after six months of deliberations and #COVID creating havoc in many countries in Latin America and India, some countries continue to oppose this landmark waiver. https://t.co/hJTR1LWfjk
— Shailly Gupta (@Shaillytweeting) April 21, 2021